The Effects of Upper Airway and Digestive Tract Tumors on the Immune System
A Pilot Study of Immunoregulatory Factor Expression and Immune Responses in Patients With Squamous Cell Carcinoma or Papilloma of the Upper Aerodigestive Tract
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)
A observational or N/A phase clinical study on Esophageal Neoplasm and Head and Neck Neoplasm, this trial is completed. The trial is conducted by National Institute on Deafness and Other Communication Disorders (NIDCD) and has accumulated 6 data snapshots since 1996. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Dec 1996
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute on Deafness and Other Communication Disorders (NIDCD)
For direct contact, visit the study record on ClinicalTrials.gov .